$34.76
0.922.72%
At close: -
$34.21
0.371.09%
Comments
Loading...
Latest Veracyte Stock News | NASDAQ:VCYT | Benzinga
Get the latest news on Veracyte stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Veracyte performance
Categories: All
Tuesday, February 25, 2025
- A Glimpse Into The Expert Outlook On Veracyte Through 5 Analysts
- Diagnostic Company Veracyte Weighs Sale For French Subsidiary, Analyst Says 'Walking Away' Is A Long-Term Positive
- UBS Maintains Buy on Veracyte, Raises Price T...
- Guggenheim Reiterates Buy on Veracyte, Mainta...
- Needham Reiterates Buy on Veracyte, Maintains...
Monday, February 24, 2025
Thursday, February 13, 2025
Wednesday, January 29, 2025
Tuesday, January 14, 2025
Thursday, December 05, 2024
Wednesday, November 27, 2024
Monday, November 18, 2024
Friday, November 08, 2024
Thursday, November 07, 2024
Wednesday, November 06, 2024
Thursday, October 17, 2024
Wednesday, October 16, 2024
Thursday, October 10, 2024
Wednesday, October 02, 2024
Monday, September 16, 2024
Wednesday, September 04, 2024
Wednesday, August 28, 2024
Wednesday, August 21, 2024
Monday, August 19, 2024
Monday, August 12, 2024
Sunday, August 11, 2024
Wednesday, August 07, 2024
- Diagnostic Tests Maker Veracyte's Q2 Is 'All-Around Very Good Quarter': Analysts Maintain Bullish View
- Shopify Posts Upbeat Earnings, Joins Axon Enterprise, Aspen Technology, Illumina, Global Payments And Other Big Stocks Moving Higher On Wednesday
- Veracyte shares are trading higher after the ...
- Needham Maintains Buy on Veracyte, Raises Pri...